MHRA: Updated guidance for Marketing Authorisation applications for medicines using the Decentralised procedure with the UK as Reference Member State (RMS)

MHRA:
Updated guidance for Marketing Authorisation applications for medicines using the Decentralised procedure with the UK as Reference Member State (RMS)
MHRA have revised and updated advice to Marketing Authorisation applicants wishing to use the Decentralised procedure with the UK as Reference Member State (RMS).